Citations

B.R.I.D.G.E. TO DATA® has been utilized in several published studies

and cited in relevant textbooks and presentations, as well as mentioned on some websites
 

Our suggested citation:
DGI, LLC. B.R.I.D.G.E. TO DATA®. (A searchable online resource of population healthcare database profiles.) Accessed MMDDYYYY. https://www.bridgetodata.org.

  1. Vlad LG, Rolley J, Vaezzadeh S, Gould L, Fife CE, Driver VR, Kapasi AJ, Ii JC, Kamani SA, Pakkal BK. Comprehensive landscape analysis for usable real-world wound care data. Wounds: a compendium of clinical research and practice. 2024 Nov;36(11):384-91.
    https://www.hmpgloballearningnetwork.com/site/wounds/comprehensive-landscape-analysis-usable-real-world-wound-care-data
  2. Sturkenboom M, FAIR Catalogue sustainability: Technical workshop on real-world metadata for regulatory purposes. Virtual meeting, April 12, 2021.
    https://www.ema.europa.eu/en/documents/presentation/presentation-session-3-fair-catalogue-sustainability-miriam-sturkenboom_en.pdf
  3. Carr MM, Schaefer EW, Schubart JR. Post-tonsillectomy outcomes in children with and without narcotics prescriptions. Ear, Nose & Throat Journal. 2021 Feb;100(2):124-9.
    https://journals.sagepub.com/doi/full/10.1177/0145561319859303
  4. Pigeot I., Tahden M., Zampatis D., Watson D.J., Forssen U., Kollhorst B. (2021) Worldwide Availability of Pharmacoepidemiological Databases. In: Sturkenboom M., Schink T. (eds) Databases for Pharmacoepidemiological Research. Springer Series on Epidemiology and Public Health. Springer, Cham.
    https://doi.org/10.1007/978-3-030-51455-6_2 
  5. Dedman D, Cabecinha M, Williams R, Evans SJ, Bhaskaran K, Douglas IJ. Approaches for combining primary care electronic health record data from multiple sources: a systematic review of observational studies. BMJ Open. 2020 Oct 1;10(10):e037405.
    https://bmjopen.bmj.com/content/10/10/e037405.abstract
  6. Xia AD, Schaefer CP, Szende A, Jahn E, Hirst MJ. RWE framework: an interactive visual tool to support a real-world evidence study design. Drugs - Real World Outcomes. 2019 Dec;6(4):193-203.
    https://link.springer.com/article/10.1007/s40801-019-00167-6
  7. Etminan M, Sodhi M, Ganjizadeh-Zavareh S, Carleton B, Kezouh A, Brophy JM. Oral fluoroquinolones and risk of mitral and aortic regurgitation. Journal of the American College of Cardiology. 2019 Sep 17;74(11):1444-50.
    https://www.jacc.org/doi/full/10.1016/j.jacc.2019.07.035
  8. Kava BR, Verbeek AE, Wruck JM, Gittelman M. Tamsulosin dispensation patterns in the United States: a real-world, longitudinal, population claims database analysis. Translational Andrology and Urology. 2019 Aug;8(4):329
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732091/
  9. Galaznik A, Reich C, Klebanov G, Khoma Y, Allakhverdiiev E, Hather G, Shou Y. Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care. Cancer Informatics. 2019 Mar;18:1176935119835538.
    https://journals.sagepub.com/doi/full/10.1177/1176935119835538
  10. Robinson DE, van Staa TP, Dennison EM, Cooper C, Dixon WG. The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: a cohort study. Bone. 2018 Dec 1;117:83-90.
    https://www.sciencedirect.com/science/article/pii/S8756328218303429
  11. Cohan S, Smoot K, Kresa-Reahl K, Garland R, Yeh WS, Wu N, Watson C. Outcomes of stable multiple sclerosis patients staying on initial interferon beta therapy versus switching to another interferon beta therapy: A US claims database study. Advances in Therapy. 2018 Nov;35(11):1894-904.
    https://link.springer.com/article/10.1007/s12325-018-0799-5
  12. Pacurariu A, Plueschke K, McGettigan P, Morales DR, Slattery J, Vogl D, Goedecke T, Kurz X, Cave A. Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation. BMJ Open. 2018 Sep 1;8(9):e023090.
    https://bmjopen.bmj.com/content/8/9/e023090.abstract
  13. Bergeron J, Doiron D, Marcon Y, Ferretti V, Fortier I. Fostering population-based cohort data discovery: The Maelstrom Research cataloguing toolkit. PLOS One. 2018 Jul 24;13(7):e0200926. 
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0200926
  14. Silva LB, Trifan A., Oliveira JL. MONTRA: An agile architecture for data publishing and discovery. Computer Methods and Programs in Biomedicine. 2018 Jul;160:33-42.
    https://www.sciencedirect.com/science/article/pii/S0169260717312725
  15. Camm AJ, Coleman CI, Larsen TB, Nielsen PB, Tamayo CS. Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban. Thrombosis and Haemostasis. 2018 May;118(S 01):S45-S60. 
    https://d-nb.info/1174471042/34
  16. Sodhi M, Sheldon CA, Carleton B, Etminan M. Risk of Pseudotumor Cerebri Syndrome (PTCS) with hormonal contraceptive use. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2018 Feb 27;7(3):778-82.
    https://www.ijrcog.org/index.php/ijrcog/article/view/4361
  17. Chen Y, Zivkovic M, Wang T, Su S, Lee J, Bortnichak EA. A Systematic Review of Coding Systems Used in Pharmacoepidemiology and Database Research. Methods of Information in Medicine. 2018 Feb;57(1):1-42.
    https://www.thieme-connect.com/products/ejournals/abstract/10.3414/ME17-05-0006
  18. Kathe N, Shah A, Said Q, Painter JT. DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case–Control Study. Diabetes Therapy. 2018 Feb;9(1):141-51.
    https://link.springer.com/article/10.1007/s13300-017-0353-5
  19. Thornton JD, Dwibedi N, Scott V, Ponte CD, Ziedonis D, Sambamoorthi N, Sambamoorthi U. Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States. American Health & Drug Benefits. 2018 Feb;11(1):12-21.
    https://europepmc.org/articles/pmc5902762
  20. Shah PS, McDonald SD, Barrett J, Synnes A, Robson K, Foster J, Pasquier JC, Joseph KS, Piedboeuf B, Lacaze-Masmonteil T, O'Brien K. The Canadian Preterm Birth Network: a study protocol for improving outcomes for preterm infants and their families. CMAJ Open. 2018 Jan;6(1):E44.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878956/
  21. Goyat, R. The Impact of Comorbidities on Diabetes and Hypertension Co-Management and Healthcare Expenditures [Dissertation]. Morgantown: West Virginia University; 2018. 3752p. 
    https://researchrepository.wvu.edu/etd/3752
  22. Sodhi, M., Risk of acute angle closure glaucoma with triptan use in migraine patients: A nested case control study [MS Thesis]. Vancouver: University of British Columbia; 2018. 103p 
    https://open.library.ubc.ca/cIRcle/collections/ubctheses/24/items/1.0375835
  23. Fortin Y. An Assessment of the Effect of Multimorbidity on Motor-Vehicle Accident Risk [PhD thesis]. Ottawa, Ontario: University of Ottawa; 2017. 368p
    https://ruor.uottawa.ca/bitstream/10393/36866/7/Fortin_Yannick_2017_thesis.pdf
  24. Fortin Y, Crispo JA., Cohen D, McNair DS, Mattison DR, Krewski D. External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality. PLOS One. 2017 Mar 28;12(3):e0174379.
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174379
  25. Schneeweiss S, Eichler HG, Garcia‐Altes A, Chinn C, Eggimann AV, Garner S, Goettsch W, Lim R, Löbker W, Martin D, Müller T. Real world data in adaptive biomedical innovation: a framework for generating evidence fit for decision‐making. Clinical Pharmacology & Therapeutics. 2016 Dec;100(6):633-46.
    https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.512
  26. Huang X, Liu Z, Shankar RR, Rajpathak S. Description of anti-diabetic drug utilization pre-and post-formulary restriction of sitagliptin: findings from a national health plan. Current Medical Research and Opinion. 2015 Aug 3;31(8):1495-500.
    https://www.tandfonline.com/doi/full/10.1185/03007995.2015.1060211
  27. Milea D, Azmi S, Reginald P, Verpillat P, Francois C. A review of accessibility of administrative healthcare databases in the Asia-Pacific region. J Mark Access Health Policy. 2015 Jul 20;3. doi: 10.3402/jmahp.v3.28076. PMID: 27123180; PMCID: PMC4802693.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802693
  28. Lopes P, Silva LB, Oliveira JL. Challenges and Opportunities for Exploring Patient-Level Data. BioMed Research International. 2015;2015:150435.
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609340/
  29. Scales CD Jr, Lai JC, Dick AW, Hanley JM, van Meijgaard J, Setodji CM, Saigal CS. Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones. Urologic Diseases in America Project. JAMA Surgery. 2014 Jul;149(7):648-53.
    https://jamanetwork.com/journals/jamasurgery/fullarticle/1871854
  30. Oshima Y, Ikematsu H, Yuji K, Tanimoto T, Tojo A. Exposure to acetaminophen and potential risk of abnormal behaviors reported in influenza and non-influenza patients. Case-control study with the Japan Adverse Drug Event Reporting. WebmedCentral Health Informatics. 2013 Dec 5;4(12):WMC004452.
    http://static.webmedcentral.com/article_view/4452
  31. Schumock GT, Lee TA, Pickard AS, Lee W, Patel H, Dilokthornsakul P, Shoaibi A, Archdeacon P. Mini-Sentinel Methods - Alternative Methods For Health Outcomes Of Interest Validation. Aug 31, 2013.
    https://www.sentinelinitiative.org/sites/default/files/surveillance-tools/validations-literature/Mini-Sentinel-Alternative-Methods-for-Health-Outcomes-of-Interest-Validation_0.pdf
  32. McKoy JM, Fisher MJ, Courtney DM, Raisch DW, Edwards BJ, Scheetz MH, Belknap SM, Trifilio SM, Samaras AT, Liebling DB, Nardone B, Tulas KM, West DP. Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project. Drug Safety. 2013 May;36(5):335-47.
     https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679367
  33. Rascati K. Essentials of Pharmacoeconomics. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2013.
    https://resource.odmu.edu.ua/chair/download/85265/S2cDkkcIkixnz4N8NoEDAQ/Book%20Essentials%20of%20Pharmacoeconomics.pdf
  34. Ryan P, Welebob E, Hartzema AG, Stang P, Overhage JM. Surveying US observational data sources and characteristics for drug safety needs. Pharmaceutical Medicine. 2010 Aug;24(4):231-8.
    https://go.gale.com/ps/i.do?p=AONE&u=googlescholar&id=GALE|A237358594&v=2.1&it=r&sid=AONE&asid=724760a7
  35. Hartzema AG, Tilson HH, Chan KA, eds. Pharmacoepidemiology and Therapeutic Risk Management. Cincinatti, OH: Harvey Whitney Books, 2008. ISBN-10: 0929375300; ISBN-13: 978-0929375304.
  36. Székács IS. Én-rendellenességek háború idején. Múlt és Jövő. 2007(3):110-115.
    https://slideum.com/doc/1239806/dr.-b%C3%A9res-judit-%E2%80%93-dr.-m%C3%A9tneki-j%C3%BAlia

Website mentions:

  1. CarolineFifeMD.com
    https://carolinefifemd.com/2020/09/01/b-r-i-d-g-e-to-data-and-the-us-wound-registry
  2. Drug consumption databases in Europe
    https://imi-protect.eu/documents/DUinventoryFeb2015.pdf
  3. Hungarian Congenital Abnormality Registry (HCAR)
    https://eu-rd-platform.jrc.ec.europa.eu/eurocat/eurocat-members/registries/hungary_en
  4. International Society for Pharmacoepidemiology (ISPE)
    https://www.pharmacoepi.org/resources/links/
  5. PsoBest
    https://www.psobest.de/en/the-registry/
  6. Respiratory Effectiveness Group
    https://www.regresearchnetwork.org/resources/useful-link/

Updated January 2024